Citicoline Injection
- Packing: 2 Ml, 4 Ml Ampoule.
- Available Strength : 125 mg/ml, 250 Mg/Ml
Description
Product Description: Citicoline Injection is a sterile solution containing citicoline, a natural compound that acts as a precursor to phospholipid synthesis in the brain. It is used to support cognitive function and enhance neuroprotection in various neurological conditions.
Indications and Usage: Citicoline Injection is indicated for the treatment of acute ischemic stroke, traumatic brain injury, and age-related cognitive decline. It is also used as an adjunctive therapy in the management of neurodegenerative disorders such as Alzheimer's disease and Parkinson's disease.
Dosage and Administration: The dosage of Citicoline Injection depends on the patient's age, weight, and clinical condition. It is administered intravenously over a period of 3 to 5 minutes. The recommended dose typically ranges from 500 mg to 2000 mg per day, divided into two or three doses.
Dosage Forms and Strengths: Citicoline Injection is available as a sterile solution in vials for intravenous administration. It is commonly supplied in concentrations of 250 mg/mL or 500 mg/mL.
Contraindications: Citicoline Injection is contraindicated in patients with hypersensitivity to citicoline or any component of the formulation. It should not be used in patients with severe renal impairment or in those with a history of hemorrhagic stroke.
Warnings and Precautions: Use caution when administering Citicoline Injection to patients with bleeding disorders or those taking anticoagulant medications, as citicoline may increase the risk of bleeding. Monitor patients closely for signs of bleeding or hematological abnormalities during treatment.
Adverse Reactions/Side Effects: Common adverse reactions associated with Citicoline Injection include headache, nausea, vomiting, and diarrhea. Rare but serious side effects may include allergic reactions, hemorrhagic stroke, or seizures. Discontinue treatment and seek medical attention if any adverse reactions occur.
Drug Interactions: Citicoline Injection may interact with other drugs that affect platelet function or coagulation, increasing the risk of bleeding. Concurrent use with anticoagulants, antiplatelet agents, or thrombolytic agents should be avoided or closely monitored.
Use In Specific Populations Description: Safety and efficacy of Citicoline Injection in pediatric patients, pregnant women, and nursing mothers have not been established. Use caution and consult with a healthcare professional before administering to individuals in these populations.
How Supplied/Storage and Handling: Citicoline Injection is supplied as a sterile solution in vials for intravenous administration. It should be stored at controlled room temperature (20°C to 25°C) away from light and moisture. Care should be taken to ensure proper storage and handling to maintain the integrity of the product. Unused portions should be discarded according to standard procedures for biohazardous waste.